Tag: Genomics

Gates and Bezos back LifeMine’s $188M fungal drug revival

LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and RA Capital, and will soon…

By

OpenAI bets on academia with free frontier AI for 100,000 scientists

OpenAI will give up to 100,000 academic researchers free access to frontier models, including 75-plus life-science tools for genomics and…

By

Mount Sinai AI model maps how genes function together in cells

Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts,…

By

How Machine Learning Is Reshaping Pharmaceutical R&D

AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…

By

ARPA-H Awards $160 Million for AI-Enabled Personalized Gene Editing to Tackle Rare Diseases

ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…

By